These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


113 related items for PubMed ID: 10930195

  • 1. Renal haemodynamics and sodium excretory capacity during urapidil treatment in patients with essential hypertension.
    Lavrijssen AT, Kroon AA, Fuss-Lejeune M, Schiffers PM, de Leeuw PW.
    J Hypertens; 2000 Jul; 18(7):963-9. PubMed ID: 10930195
    [Abstract] [Full Text] [Related]

  • 2. Renal haemodynamic and neurohumoral responses to urapidil in hypertensive man.
    de Leeuw PW, van Es PN, de Bruyn HA, Birkenhäger WH.
    Drugs; 1988 Jul; 35 Suppl 6():74-7. PubMed ID: 2900132
    [Abstract] [Full Text] [Related]

  • 3. Effects of prostacyclin on renal haemodynamics, renal tubular function and vasoactive hormones in healthy humans. A placebo-controlled dose-response study.
    Nielsen CB, Bech JN, Pedersen EB.
    Br J Clin Pharmacol; 1997 Nov; 44(5):471-6. PubMed ID: 9384464
    [Abstract] [Full Text] [Related]

  • 4. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
    Sánchez RA, Marcó E, Gilbert HB, Raffaele P, Brito M, Giménez M, Moledo LI.
    Drugs; 1985 Nov; 30 Suppl 1():49-58. PubMed ID: 2994987
    [Abstract] [Full Text] [Related]

  • 5. Effect of pinacidil on renal haemodynamics, tubular function and plasma levels of angiotensin II, aldosterone and atrial natriuretic peptide in healthy man.
    Nielsen CB, Pedersen EB.
    Eur J Clin Pharmacol; 1993 Nov; 45(1):29-35. PubMed ID: 8405026
    [Abstract] [Full Text] [Related]

  • 6. Acute responses to urapidil in hypertensive persons.
    de Leeuw PW, Birkenhäger WH.
    Am J Cardiol; 1989 Aug 15; 64(7):22D-24D. PubMed ID: 2667310
    [Abstract] [Full Text] [Related]

  • 7. Glomerular hyperfiltration in essential hypertension: hormonal aspects.
    Regolisti G, Buzio C, Cavatorta A, De Martin L, Cavalli R, Perazzoli F, Coghi P, Cabassi A, Pucci F, Borghetti A.
    Acta Biomed Ateneo Parmense; 1992 Aug 15; 63(1-2):163-73. PubMed ID: 1340661
    [Abstract] [Full Text] [Related]

  • 8. Family history and pathophysiological mechanisms of primary hypertension. Studies in non-hypertensive young men with positive and negative family histories of hypertension.
    Widgren BR.
    Scand J Urol Nephrol Suppl; 1991 Aug 15; 134():1-75. PubMed ID: 1887213
    [Abstract] [Full Text] [Related]

  • 9. Glomerular and tubular antinatriuretic actions of low-dose angiotensin II infusion in man.
    Eiskjaer H, Sørensen SS, Danielsen H, Pedersen EB.
    J Hypertens; 1992 Sep 15; 10(9):1033-40. PubMed ID: 1328362
    [Abstract] [Full Text] [Related]

  • 10. Effects of angiotensin converting enzyme inhibitor on renal haemodynamics during mental stress.
    Schmieder RE, Schobel HP, Gatzka CE, Häuser W, Dominiak P, Mann JF, Luft FC.
    J Hypertens; 1996 Oct 15; 14(10):1201-7. PubMed ID: 8906519
    [Abstract] [Full Text] [Related]

  • 11. The interaction between atrial natriuretic peptides and angiotensin II in controlling sodium and water excretion in the rat.
    Chamienia AL, Johns EJ.
    Br J Pharmacol; 1991 Aug 15; 103(4):1893-8. PubMed ID: 1833019
    [Abstract] [Full Text] [Related]

  • 12. Effects of statins on renal sodium and water handling: acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans.
    Paulsen L, Holm C, Bech JN, Starklint J, Pedersen EB.
    Nephrol Dial Transplant; 2008 May 15; 23(5):1556-61. PubMed ID: 18065809
    [Abstract] [Full Text] [Related]

  • 13. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
    Semplicini A, Ceolotto G, Sartori M, Maresca A, Baritono E, De Toni R, Paparella I, Calò L.
    J Nephrol; 2002 May 15; 15(5):489-96. PubMed ID: 12455714
    [Abstract] [Full Text] [Related]

  • 14. Abnormal increase in urinary aquaporin-2 excretion in response to hypertonic saline in essential hypertension.
    Graffe CC, Bech JN, Lauridsen TG, Vase H, Pedersen EB.
    BMC Nephrol; 2012 Mar 27; 13():15. PubMed ID: 22452789
    [Abstract] [Full Text] [Related]

  • 15. Cardiovascular and metabolic profile during intervention with urapidil in humans.
    Gerber A, Weidmann P, Marone C, Uehlinger D, Riesen W.
    Hypertension; 1985 Mar 27; 7(6 Pt 1):963-71. PubMed ID: 3908316
    [Abstract] [Full Text] [Related]

  • 16. The acute effects of FK-506 on renal haemodynamics, water and sodium excretion and plasma levels of angiotensin II, aldosterone, atrial natriuretic peptide and vasopressin in pigs.
    Golbaekdal K, Nielsen CB, Pedersen EB.
    J Pharm Pharmacol; 1996 Nov 27; 48(11):1174-9. PubMed ID: 8961168
    [Abstract] [Full Text] [Related]

  • 17. Responses of plasma catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide to exercise in patients with essential hypertension.
    Kinugawa T, Endo A, Kato M, Kato T, Ahmmed GU, Omodani H, Osaki S, Ogino K, Hisatome I, Miyakoda H, Fujimoto Y, Yoshida A, Shigemasa C.
    Cardiology; 1997 Nov 27; 88(3):238-45. PubMed ID: 9129844
    [Abstract] [Full Text] [Related]

  • 18. Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease.
    Torres VE, Wilson DM, Burnett JC, Johnson CM, Offord KP.
    Mayo Clin Proc; 1991 Oct 27; 66(10):1010-7. PubMed ID: 1921483
    [Abstract] [Full Text] [Related]

  • 19. Role of atrial natriuretic factor in changes in the responsiveness of aldosterone to angiotensin II secondary to sodium loading and depletion in man.
    Tuchelt H, Eschenhagen G, Bähr V, Schwietzer G, Thiede HM, Oelkers W.
    Clin Sci (Lond); 1990 Jul 27; 79(1):57-65. PubMed ID: 2167792
    [Abstract] [Full Text] [Related]

  • 20. Effect of intravenous glucagon infusion on renal haemodynamics and renal tubular handling of sodium in healthy humans.
    Schwartz Sørensen S, Eiskjaer H, Orskov H, Bjerregaard Pedersen E.
    Scand J Clin Lab Invest; 1993 Feb 27; 53(1):25-34. PubMed ID: 8451599
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.